Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy Induced Neutropenia”

111 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 111 results

Large-scale testing (Phase 3)Study completedNCT01079676
What this trial is testing

A Non-inferiority Study Comparing Two Filgrastim Preparations in Breast Cancer

Who this might be right for
Neutropenia in Breast Cancer
Eurofarma Laboratorios S.A. 220
Not applicableStudy completedNCT02178475
What this trial is testing

Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy

Who this might be right for
Chemotherapy-induced Febrile Neutropenia
Amgen 943
Large-scale testing (Phase 3)Study completedNCT00776165
What this trial is testing

Safety and Efficacy Trial of Recombinant Human Granulocyte Colony Stimulating Factor (GCSF)

Who this might be right for
Chemotherapy-Induced Neutropenia
Shantha Biotechnics Limited 126
Early research (Phase 1)Study completedNCT03246009
What this trial is testing

Fusion Protein rHSA/GCSFclinical Study on Breast Cancer Patients

Who this might be right for
Chemotherapy-induced NeutropeniaCancer, Breast
Tianjin SinoBiotech Ltd. 24
Large-scale testing (Phase 3)Study completedNCT00837265
What this trial is testing

Balugrastim (Neugranin) in Breast Cancer Participants Receiving Doxorubicin/Docetaxel

Who this might be right for
Chemotherapy-induced Neutropenia
Teva Branded Pharmaceutical Products R&D, Inc. 334
Post-approval studies (Phase 4)Looking for participantsNCT06616571
What this trial is testing

Compare the Efficacy and Safety of QL0605 Injections at Different Timepoints

Who this might be right for
Chemotherapy-Induced Febrile Neutropenia
Qilu Pharmaceutical Co., Ltd. 336
Large-scale testing (Phase 3)Study completedNCT05221593
What this trial is testing

Efficacy of Lithium Against Chemotherapy Induced Neutropenia in Breast Cancer Patients

Who this might be right for
Neutropenia
Al-Azhar University 50
Testing effectiveness (Phase 2)Study completedNCT02465801
What this trial is testing

Study of Recombinant Human Serum Albumin/Granulocyte Colony-Stimulating Factor Fusion Protein

Who this might be right for
Chemotherapy-induced Neutropenia
Tianjin SinoBiotech Ltd. 216
Early research (Phase 1)Study completedNCT02532712
What this trial is testing

Study to Evaluate the Safety, Tolerability and PK of EC-18 After Oral Administration in Healthy Volunteers

Who this might be right for
Chemotherapy-Induced Neutropenia
Enzychem Lifesciences Corporation 64
Testing effectiveness (Phase 2)Study completedNCT04345900
What this trial is testing

Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 2

Who this might be right for
Chemotherapy-induced Neutropenia
BeyondSpring Pharmaceuticals Inc. 55
Large-scale testing (Phase 3)Not Yet RecruitingNCT07483736
What this trial is testing

Efficacy of an Empirical Treatment With Amoxicillin-clavulanate (AC) Compared to the Combination Amoxicillin-clavulanate and Ciprofloxacin (AC+C) in the Outpatient Care of Chemotherapy-induced Fever in Adult Haematology Patients.

Who this might be right for
C15.378
Versailles Hospital 1,526
Post-approval studies (Phase 4)UnknownNCT03793205
What this trial is testing

G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer Patients

Who this might be right for
Gynecologic CancerMyelosuppression AdultFebrile Neutropenia+1 more
Lei Li 100
Large-scale testing (Phase 3)Study completedNCT01516736
What this trial is testing

Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim

Who this might be right for
Chemotherapy-induced NeutropeniaBreast Cancer
Sandoz 308
Not applicableLooking for participantsNCT07096479
What this trial is testing

Telpegfilgrastim Injection to Reduce the Risk of Neutropenia in Patients With Solid Tumor

Who this might be right for
Chemotherapy-induced Neutropenia
Anhui Provincial Hospital 318
Testing effectiveness (Phase 2)Study completedNCT02005458
What this trial is testing

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy

Who this might be right for
Non Small Cell Lung CancerBreast Cancer
Xiamen Amoytop Biotech Co., Ltd. 80
Not applicableStudy completedNCT01813721
What this trial is testing

Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy.

Who this might be right for
Chemotherapy-induced Febrile Neutropenia
Amgen 1,007
Testing effectiveness (Phase 2)Study completedNCT02282215
What this trial is testing

Safety and Efficacy of Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaNeutropeniaInfection
Cellerant Therapeutics 163
Testing effectiveness (Phase 2)Ended earlyNCT03559387
What this trial is testing

Randomized Phase 2, Dose-finding Efficacy, Safety Study of ANF-RHO™ Versus Neulasta® in Chemotherapy-Induced Neutropenia

Who this might be right for
Chemotherapy-induced Neutropenia
Prolong Pharmaceuticals 9
Large-scale testing (Phase 3)Study completedNCT04174599
What this trial is testing

Study to Compare the Efficacy and Safety of F-627 and GRAN®

Who this might be right for
Breast CancerNeutropenia
EVIVE Biotechnology 242
Not applicableStudy completedNCT02428114
What this trial is testing

A Multi Centre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Standard of Care Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia in Early Stage Breast Cancer (React-G Study)

Who this might be right for
Early Stage Breast Cancer
Ottawa Hospital Research Institute 142
Load More Results